AF647 Anti-Human CD39 Antibody[A1]

AF647 Anti-Human CD39 Antibody[A1]

The AF647 Anti-Human CD39 Antibody [A1] is a highly specific and reliable tool designed for the detection and analysis of CD39 expression in human samples. This monoclonal antibody is conjugated with AF647, a bright and photostable fluorescent dye, enabling efficient and accurate visualization of CD39 protein in various experimental applications.

CD39, also known as ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1), is a cell surface protein predominantly expressed on immune cells, including T cells, B cells, and natural killer cells. It plays a crucial role in regulating immune responses by hydrolyzing extracellular ATP and ADP into AMP, thereby modulating purinergic signaling. Dysregulation of CD39 has been implicated in various pathological conditions, including autoimmune diseases, cancer, and inflammation.

The AF647 Anti-Human CD39 Antibody [A1] has been extensively validated for its specificity and sensitivity in immunofluorescence, flow cytometry, and immunohistochemistry applications. It exhibits minimal cross-reactivity with other related proteins, ensuring accurate and reliable results. The AF647 conjugation provides excellent signal-to-noise ratio and high photostability, allowing for prolonged imaging and analysis without compromising data quality.

This antibody is supplied as a liquid formulation in a convenient size of 100 µg, ensuring sufficient quantity for multiple experiments. It is recommended for use in both research and clinical settings, enabling the investigation of CD39 expression patterns in various human tissues and cell types. The AF647 Anti-Human CD39 Antibody [A1] offers researchers a valuable tool to advance their understanding of CD39 biology and its implications in disease pathogenesis, ultimately contributing to the development of novel therapeutic strategies.